New York 2023-2024 Regular Session

New York Senate Bill S02393

Introduced
1/20/23  
Refer
1/20/23  
Refer
1/3/24  

Caption

Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.

Companion Bills

NY A01962

Same As Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.

Previously Filed As

NY A01962

Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.

NY S02128

Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.

NY A07142

Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.

NY HB1270

Health Benefit Plans - Prescription Drugs - Rebates and Calculation of Cost Sharing Requirements

NY SB1019

Health Benefit Plans - Prescription Drugs - Rebates and Calculation of Cost Sharing Requirements

NY HB509

Apply prescription drug rebates to cost-sharing requirements

NY SB2031

Health insurance carriers; require to cap patient cost for prescriptions for insulin drugs.

NY SB2223

Health insurance carriers; require to cap patient cost for prescriptions for insulin drugs.

NY SB2027

Health insurance carriers; require to cap patient cost for prescriptions for insulin drugs.

NY HB343

Lowering Prescription Drug Costs for Patients Act; enact

Similar Bills

No similar bills found.